SMTL ID : 6t8u.3 (2 other biounits)

Complement factor B in complex with 5-Bromo-3-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-7-methyl-1H-indol-4-amine

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.84 Å

Oligo State

monomer

Ligands

1 x MVZ: 5-bromanyl-3-chloranyl-~{N}-(1~{H}-imidazol-2-yl)-7-methyl-1~{H}-indol-4-amine(Non-covalent)

MVZ.1: 15 residues within 4Å: Chain A: E.98, Y.100, A.190, P.191, T.221, C.222, R.223, S.226, S.245, W.246, G.247, V.248, V.249, D.250 Ligands: SO4.3 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:R.223, A:G.247, A:G.247 Halogen bonds: A:Y.100

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 2 residues within 4Å: Chain A: P.205, R.206 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:R.206 SO4.3: 4 residues within 4Å: Chain A: E.98, P.191, R.223 Ligands: MVZ.1 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:E.98 Salt bridges: A:R.223

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mainolfi, N. et al., Discovery of 4-((2S,4S)-4-Ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases. J.Med.Chem. (2020)

Release Date

2020-03-04

Peptides

Complement factor B: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
CCC

Complement factor B

Related Entries With Identical Sequence